ACRV Latest Quarter's Earnings
| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $-0.47 (Beat by $0.1) |
| EPS GAAP Actual | $-0.47 (Beat by $0.1) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
Upcoming Quarter's Earnings
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.64 |
| EPS GAAP Estimate | $-0.64 |
| Revenue Estimate | $0.0005B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -2.47667 | -0.67 | -2.47667 | -2.47667 | 2 |
| Dec 2029 | -1.19092 | -1.4 | -1.19092 | -1.19092 | 1 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.47 | 0.24333 | 0B | NAN% | 0M |
| FQ2 2025 (Jun 2025) | -0.55 | 0.41355 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -0.51 | 0.3825 | 0B | NAN% | 0M |
| FQ4 2024 (Dec 2024) | -0.12 | 0.45904 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | -0.59 | 0.00671 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.0005 | -1.34309 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.73 | -0.73 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | -0.86 | -0.86 | 0B | NAN% | 0M |
Quarterly Estimates Summary
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.64
Consensus Revenue Estimates
0.0005B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | -0.7 | -- | -0.7 | -0.7 | 1 |
| FQ3 2026 (Sep 2026) | -0.7 | 32.86 | -0.7 | -0.7 | 1 |
| FQ2 2026 (Jun 2026) | -0.69 | 20.29 | -0.69 | -0.69 | 1 |
| FQ1 2026 (Mar 2026) | -0.64 | 20.31 | -0.64 | -0.64 | 1 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 1 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 1 |
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 1 |
| FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 1 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.71333 | -0.47 | 0.24333 | -51.77% |
| FQ2 2025 (Jun 2025) | -0.96355 | -0.55 | 0.41355 | -75.19% |
| FQ1 2025 (Mar 2025) | -0.8925 | -0.51 | 0.3825 | -75% |
| FQ4 2024 (Dec 2024) | -0.57904 | -0.12 | 0.45904 | -382.53% |
| FQ3 2024 (Sep 2024) | -0.59671 | -0.59 | 0.00671 | -1.14% |
| FQ2 2024 (Jun 2024) | 1.34259 | -0.0005 | -1.34309 | 268618% |
| FQ1 2024 (Mar 2024) | -0.73 | -0.73 | 100% | |
| FQ4 2023 (Dec 2023) | -0.86 | -0.86 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
ACRV Ratings Summary
ACRV Quant Ranking
